USA flag logo/image

An Official Website of the United States Government

Carbon Nanopipette Cellular Probe for Microinjections into Mammalian Cells

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
96169
Program Year/Program:
2010 / SBIR
Agency Tracking Number:
GM087793
Solicitation Year:
N/A
Solicitation Topic Code:
NIGMS
Solicitation Number:
N/A
Small Business Information
VEGRANDIS, LLC
VEGRANDIS, LLC 535 W. Research Blvd., Suite 135, M/S 200 FAYETTEVILLE, AR 72701
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2010
Title: Carbon Nanopipette Cellular Probe for Microinjections into Mammalian Cells
Agency: HHS
Contract: 1R43GM087793-01A1
Award Amount: $201,017.00
 

Abstract:

DESCRIPTION (provided by applicant): The main goal of this Phase I SBIR project is to demonstrate the feasibility of using a novel carbon-based nanopipette (CNP) for precise and controlled microinjection of macromolecules into single cells and allow electr ical measurement of variations in membrane potential upon penetrating a cell. The ultimate goal is to develop a unique and versatile nanopipette device for concurrent microinjection and electrical measurements of changes in cell membrane potential upon pen etration of a cell. CNP fabrication does not require any cumbersome assembly. The CNP consists of a pulled glass capillary terminating with an exposed carbon tip with a diameter ranging from tens to hundreds of nanometers. A thin carbon film coated inside the glass capillary of the CNP provides an electrically conducting path that can be used as an electrode for measurement of changes in membrane potential in cells. In addition, these devices can inject chemicals and macromolecules into single cells and ext ract fluids and specific proteins from cell's interior. The CNPs offer significant advantages over the commonly used pulled glass pipettes such as smaller size (minimal damage to cells and the ability to probe organelles), better mechanical properties, hig her durability (they do not break or clog easily), potential for automation (the cell's penetration can be sensed through an electric signal), potential to carry out electrophysiological measurements concurrently with injection, and multifunctional analyti c capabilities while being competitive in price with the glass micropipettes. Moreover, given their durability, the CNPs offer higher efficiency and lower cost (on a per cell basis) than their glass counterparts. The feasibility of the CNP to inject into t he cytoplasm and inject into the nucleus with higher cell survival rates will be tested and compared to that of commercially available micropipettes to demonstrate the advantages of CNPs in microinjection. Furthermore, the unique characteristic of CNPs as nanoelectrodes will be demonstrated by measuring the change in electrical signal upon cell penetration. Feasibility studies will be performed using CNPs with inner diameter in the ~100 nm range to achieve less damage to cell membrane upon cell penetration. PUBLIC HEALTH RELEVANCE: The proposed CNP devices will have applications in manipulation and study of individual cells including facilitating controlled injection of proteins and nucleic acids, drug delivery, biomedical diagnostics, and cellular en gineering research. Direct comparison of microinjection using CNP to commercially available glass micropipettes will allow advancement in single cell microinjection applications by replacing the conventional glass micropipettes with CNPs.

Principal Investigator:

Chamika Wansapura
4795712592
CHAMIKA.WANSAPURA@VEGRANDIS.COM

Business Contact:

Calvin Goforth
mwagstaff@virtual-incubation.com
Small Business Information at Submission:

VEGRANDIS, LLC
VEGRANDIS, LLC 535 W. Research Blvd., Suite 135, M/S 200 FAYETTEVILLE, AR 72701

EIN/Tax ID: 111368222
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No